Cargando…

Case Report: Treatment of a Severe Puff Adder Snakebite Without Antivenom Administration

Antivenoms are the treatment of choice for managing lethal snakebites. However, antivenoms may not be available in instances where non-native vipers are kept in captivity. We report a case of a puff adder (Bitis arietans) bite treated without antivenom. A 23-year-old man was bitten on his left hand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakasugi, Masahiro, Kawagishi, Toshiomi, Hatano, Tomoya, Shibuya, Tadaki, Kuwano, Hiroyuki, Matsui, Kotaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2021
Materias:	Clinical Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437168/ https://www.ncbi.nlm.nih.gov/pubmed/34181572 http://dx.doi.org/10.4269/ajtmh.21-0291

Ejemplares similares

In Vitro Toxic Effects of Puff Adder (Bitis arietans) Venom, and Their Neutralization by Antivenom
por: Fernandez, Steven, et al.
Publicado: (2014)

Death Adder Envenoming Causes Neurotoxicity Not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
por: Johnston, Christopher I., et al.
Publicado: (2012)

Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19()
por: Sakamaki, Ippei, et al.
Publicado: (2020)

Effect of Advanced Airway Management by Paramedics During Out-of-Hospital Cardiac Arrest on Chest Compression Fraction and Return of Spontaneous Circulation
por: Shimizu, Koji, et al.
Publicado: (2021)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
por: Terashige, Shou, et al.
Publicado: (2021)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Recent Advances in Next Generation Snakebite Antivenoms
por: Knudsen, Cecilie, et al.
Publicado: (2018)

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)

Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana
por: Houcke, Stéphanie, et al.
Publicado: (2023)

Effective, polyvalent, affordable antivenom needed to treat snakebite in Nepal
por: Shrestha, Bhola R, et al.
Publicado: (2017)

Effectiveness of repeated antivenom therapy for snakebite-related systemic complications
por: Park, Kyung Hoon, et al.
Publicado: (2019)

The effect of physiological levels of South African puff adder (Bitis arietans) snake venom on blood cells: an in vitro model
por: Strydom, Morné A., et al.
Publicado: (2016)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa
por: Hamza, Muhammad, et al.
Publicado: (2016)

Antibacterial Activity of Venom from the Puff Adder (Bitis arietans), Egyptian Cobra (Naja haje), and Red Spitting Cobra (Naja pallida)
por: Okumu, Mitchel Otieno, et al.
Publicado: (2023)

Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
por: Gutiérrez, José María, et al.
Publicado: (2017)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019)

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis
por: Isaacson, Julia Elizabeth, et al.
Publicado: (2023)

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
por: Laustsen, Andreas H., et al.
Publicado: (2017)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
por: Adrião, Asenate A. X., et al.
Publicado: (2022)

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
por: Dalhat, Mahmood Muazu, et al.
Publicado: (2023)

African Adders: Partial Characterization of Snake Venoms from Three Bitis Species of Medical Importance and Their Neutralization by Experimental Equine Antivenoms
por: Paixão-Cavalcante, Danielle, et al.
Publicado: (2015)

Green medicine as a harmonizing tool to antivenom therapy for the clinical management of snakebite: The road ahead
por: Mukherjee, Ashis K.
Publicado: (2012)

Potential Utilization of a Polysaccharide from the Marine Algae Gayralia oxysperma, as an Antivenom for Viperidae Snakebites
por: da Silva, Ana Cláudia Rodrigues, et al.
Publicado: (2018)

A painful journey to antivenom: The therapeutic itinerary of snakebite patients in the Brazilian Amazon (The QUALISnake Study)
por: Cristino, Joseir Saturnino, et al.
Publicado: (2021)

Anti-Metalloprotease P-I Single-Domain Antibodies: Tools for Next-Generation Snakebite Antivenoms
por: Silva, Marcela C. S., et al.
Publicado: (2022)

Identifying high snakebite risk area under climate change for community education and antivenom distribution
por: Yousefi, Masoud, et al.
Publicado: (2023)

The Puff Direct
Publicado: (1904)

A Puff
Publicado: (1869)

Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa
por: Harrison, Robert A., et al.
Publicado: (2017)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
por: Alirol, Emilie, et al.
Publicado: (2017)

Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots
por: Senji Laxme, R. R., et al.
Publicado: (2021)

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
por: Alomran, Nessrin, et al.
Publicado: (2022)

The Forbidden Quantum Adder
por: Alvarez-Rodriguez, U., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_knbjbpibsnbfns72r3j191gnaj